Interim Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues:
Net patient revenues	$ 244,095,000	$ 236,111,000
Other revenues	12,029,000	12,174,000
Net operating revenues	256,124,000	248,285,000
Cost and expenses:
Salaries, wages and benefits	147,469,000	141,388,000
Other operating	71,668,000	69,432,000
Facility rent	10,332,000	10,238,000
Depreciation and amortization	10,438,000	10,517,000
Interest	412,000	926,000
Total costs and expenses	240,319,000	232,501,000
Income from operations	15,805,000	15,784,000
Other income:
Non–operating income	8,146,000	6,001,000
Unrealized gains/(losses) on marketable equity securities	(60,392,000)	6,838,000
Income/(loss) before income taxes	(36,441,000)	28,623,000
Income tax (provision)/benefit	9,625,000	(7,392,000)
Net income/(loss)	(26,816,000)	21,231,000
(Income)/loss attributable to noncontrolling interest	(36,000)	38,000
Net income/(loss) attributable to National HealthCare Corporation	$ (26,852,000)	$ 21,269,000
Earnings/(loss) per share attributable to National HealthCare Corporation stockholders:
Basic (in dollars per share)	$ (1.76)	$ 1.39
Diluted (in dollars per share)	$ (1.76)	$ 1.39
Basic (in shares)	15,294,777	15,256,189
Diluted (in shares)	15,294,777	15,324,125
Dividends declared per common share (in dollars per share)	$ 0.52	$ 0.50